Immunome Statistics
NASDAQ: IMNMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
18.60-0.495 (-2.59%)
Market open · Delayed 15 min · as of Oct 8, 10:56 AM ET
Immunome by the numbers
Immunome has a market capitalization of $2.19 billion based on 118.00M shares outstanding. With trailing EPS of $-2.52, Immunome is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 25.9% below its 50-day average and 18.2% below its 200-day average.
Average daily trading volume is 1.19M shares, or about $22.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IMNM valuation vs. peer median
| Metric | IMNM | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.19B | $2.24B | -2% |
| Avg. volume | 1.19M | 809.98K | +47% |
Peer median across 8 companies: BHC, HRMY, IRON, NRIX, PBH, SLS, HCM, PHVS.
Valuation
- Market cap
- $2.19B
- EPS (TTM)
- $-2.52
- Shares outstanding
- 118.00M
Price and trading
- Previous close
- 19.10
- Open
- 18.88
- Day range
- 18.53 – 18.98
- 52-week range
- 13.49 – 30.06
- 52-week change
- +38.17%
- Beta
- —
- Volume
- 259.22K
- Average volume
- 1.19M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 2.19B
- Forward Pe
- -7.66
- Eps
- -2.52
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 30.06
- Week52 Low
- 13.49
- Avg Volume
- 1.19M
- Shares Outstanding
- 118.00M
- Ma50
- 25.09
- Ma200
- 22.74
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -38.12%
- Pct From52w Low
- 37.88%